Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
May 7, 2018
VBL Therapeutics to Present Data on its MOSPD2 Oncology Program at MIXiii-BIOMED 2018 on May 15
TEL AVIV, Israel, May 07, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class ...
May 7, 2018
BioDelivery Sciences Appoints Herm Cukier as Chief Executive Officer
RALEIGH, N.C., May 07, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (BDSI), a specialty pharmaceutical company with a focus in pain management and addiction ...
May 7, 2018
Lipocine Announces Financial and Operational Results for the First Quarter Ended March 31, 2018
SALT LAKE CITY, May 7, 2018 /PRNewswire/ -- Lipocine Inc. (LPCN), a specialty pharmaceutical company, today announced financial results for the first quarter ended March 31, ...
May 7, 2018
BrainsWay Receives FDA Clearance of Next Generation Stimulator, Enhancing Its Current Deep Transcranial Magnetic Stimulation (Deep TMS) System for Treatment of Major Depressive Disorder
HACKENSACK, N.J., May 07, 2018 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (BRIN.TA), the parent company of BrainsWay USA, Inc., and a global leader in the advanced ...
May 7, 2018
Foamix Announces Dosing of Last Patient in Third Phase 3 Acne Study for Minocycline Foam FMX101
REHOVOT, Israel, and BRIDGEWATER, N.J., May 07, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (FOMX), a clinical stage specialty pharmaceutical company focused on developing and ...
May 7, 2018
Rexahn Reports First Quarter 2018 Financial Results
ROCKVILLE, Md., May 07, 2018 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American:RNN), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment ...
May 7, 2018
HTG Molecular Diagnostics and Firalis Announce an Agreement Enabling Firalis’ Commercialization of Theranostic and Research Products and Services Based on HTG EdgeSeq Technology
TUCSON, Ariz. and HUNINGUE, France, May 07, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (HTGM) (“HTG”), a provider of instruments, reagents and services for ...
May 7, 2018
Krystal Biotech Reports First Quarter 2018 Financial Results and Provides Corporate Update
PITTSBURGH, May 07, 2018 (GLOBE NEWSWIRE) -- Krystal Biotech (KRYS), a gene therapy company advancing “off-the-shelf” topical and intra-dermal treatments for dermatological diseases, today reports ...
May 3, 2018
Celyad Successfully Administers CYAD-01 in First Patients in SHRINK and LINK Trials
MONT-SAINT-GUIBERT, Belgium, May 03, 2018 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels:CYAD) (CYAD) (CYAD) a clinical-stage biopharmaceutical company focused on the development of CAR-T cell therapies, ...
May 3, 2018
World Health Organization Grants Name ‘Seliforant’ to Sensorion’s SENS-111 Treatment
MONTPELLIER, France, May 03, 2018 (GLOBE NEWSWIRE) -- Sensorion (FR0012596468 – ALSEN), a biotech company specializing in the treatment of inner ear diseases, today announces ...
May 3, 2018
Minerva Neurosciences Reports First Quarter 2018 Financial Results and Business Updates
WALTHAM, Mass., May 03, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central ...
May 3, 2018
Catalyst Biosciences Reports First Quarter Operating & Financial Results and Provides Corporate Update
SOUTH SAN FRANCISCO, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (CBIO), today announced operating and financial results for the first quarter ending ...
May 3, 2018
BioLife Solutions to Report First Quarter 2018 Financial Results and Provide Business Update on May 10, 2018
BOTHELL, Wash., May 3, 2018 /PRNewswire/ -- BioLife Solutions, Inc. (BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze ...
May 3, 2018
Opiant Pharmaceuticals To Host Key Opinion Leader Meeting on Medications for Addictions and Related Disorders
SANTA MONICA, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. ("Opiant") (OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions, will host ...
May 3, 2018
BioDelivery Sciences Confirms Receipt of Notice of Intent to Nominate Directors by Broadfin Capital
RALEIGH, N.C., May 03, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (BDSI) today issued the following statement with respect to its receipt of a ...
May 3, 2018
Vermillion to Report First Quarter 2018 Financial Results on Monday, May 14
AUSTIN, Texas, May 03, 2018 (GLOBE NEWSWIRE) -- Vermillion, Inc. (VRML), a bio-analytical solutions company focused on gynecologic disease, announced today that it will report ...
May 3, 2018
Gemphire Therapeutics Announces the Appointment of Steven Gullans, Ph.D., as President and Chief Executive Officer
LIVONIA, Mich., May 03, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, ...
May 3, 2018
TherapeuticsMD Announces First Quarter 2018 Financial Results
BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (TXMD), an innovative women’s healthcare company, today announced its financial results for the quarter ended March 31, 2018. ...
May 1, 2018
BioTime Presents Updated OpRegen® Clinical Trial Data at ARVO
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced that an abstract related to one of its ...
May 1, 2018
Arena Pharmaceuticals and Outpost Medicine Enter into Licensing Agreement for Undisclosed Novel Compound
SAN DIEGO and INDIANAPOLIS, May 1, 2018 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (ARNA), a biopharmaceutical company focused on developing novel, small molecule drugs across multiple therapeutic ...
Page 66 of 138